Tirzepatide (brand name Mounjaro) is an injectable medication which helps manage obesity by reducing appetite and supporting weight loss
Dubbed a triple-hormone powerhouse , Retatrutide is showing unprecedented results in early trials
Use of MOUNJARO for this indication is supported by a 30-week, randomized, double-blind, placebo-controlled trial with a 22-week open label extension in 99 pediatric patients [see Clinical Studies (14.5)]
Related Reading Your Glp 1 Diet Plan Should Match Your Genetics Heres What That Means Why Isnt My Glp 1 Working Your Genetics May Have The Answer How Do Genetics Affect My Body S Response To Stress Hormones How Do Genetics Affect My Body S Response To Birth Control Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Cell death was assessed after 16 h by LDH release assay